chr8-102218827-A-C
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_015713.5(RRM2B):āc.671T>Gā(p.Ile224Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,612,456 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_015713.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RRM2B | NM_015713.5 | c.671T>G | p.Ile224Ser | missense_variant | 6/9 | ENST00000251810.8 | NP_056528.2 | |
RRM2B | NM_001172477.1 | c.887T>G | p.Ile296Ser | missense_variant | 6/9 | NP_001165948.1 | ||
RRM2B | NM_001172478.2 | c.515T>G | p.Ile172Ser | missense_variant | 5/8 | NP_001165949.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RRM2B | ENST00000251810.8 | c.671T>G | p.Ile224Ser | missense_variant | 6/9 | 1 | NM_015713.5 | ENSP00000251810.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152056Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251124Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135738
GnomAD4 exome AF: 0.0000240 AC: 35AN: 1460400Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 726646
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152056Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74258
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 224 of the RRM2B protein (p.Ile224Ser). This variant is present in population databases (rs515726196, gnomAD 0.004%). This missense change has been observed in individuals with autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions and autosomal recessive mitochondrial DNA depletion syndrome (PMID: 18504129, 23107649, 31462754; Invitae). ClinVar contains an entry for this variant (Variation ID: 132122). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RRM2B protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 28, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18504129, 30049826, 23107649, 24741716) - |
RRM2B-related mitochondrial disease Other:2
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpreted as Pathogenic and reported on 05-12-2016 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction;C2749861:Mitochondrial DNA depletion syndrome 8a;C2751319:Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 27, 2022 | - - |
Mitochondrial DNA depletion syndrome 8a Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Translational Omics - GOSgene, University College London | Mar 16, 2018 | - - |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | research | Neurogenomics Lab, Neuroscience Institute, University Of Cape Town | Sep 24, 2024 | The highest population allele frequency in gnomAD v4.0 is 0.00003127 (0.003%; 2/63966 alleles in the European/Finnish population). PP3_Strong: Revel score is 0.987. PP1 Not Met: 1 informative meiosis in 1 family (clinical testing). PS4_Moderate: 5 unrelated probands with consistent phenotype for disorder (PMID:23107649, PMID:24086434). Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at